neonatal cholestasis. Machine learning techniques can provide a robust multivariate approach with multiple features taken into account simultaneously, without the need for variable selection [4] .
Ultrasonography (US) and hepatobiliary scintigraphy are helpful investigations, however, they still require liver biopsy and/or intraoperative cholangiography for the definitive diagnosis of BA. Abdominal US in BA shows an enlarged liver, absence of biliary dilation, and an absent or contracted gallbladder after 4 h fasting. A triangular cord sign considered as a specific finding in BA has been reported with its sensitivities varying from 49% and 73% [2, 5] .Hepatobiliary scintigraphy is useful for excluding BA. Its sensitivity is high (98.7%), however its specificity for a differentiate diagnosis BA is relatively low (33%-80%) [6, 7] .Dong et al. [3] did not include US and hepatobiliary scintigraphy in their study. Recently, it was reported that phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of BA with high accuracy (sensitivity, 100%; specificity, 93%; accuracy 94.6%) [8] .More recently, Kim et al. [9] reported that a new scoring system combining clinical, US findings and hepatobiliary scintigraphy can help to arrive at an accurate diagnosis for BA in patients with neonatal cholestasis. This scoring system was able to differentiate biliary atresia in the derivation cohort (C statistic, 0.981; 95% confidence interval [CI]: 0.970, 0.992) and the validation cohort (C statistic, 0.995; 95% CI: 0.987, 1.000) [9] . Recently, it was reported that MRI-based decision tree model for diagnosis of BA improved the accuracy of a differential diagnosis between BA and other cases of infant cholestasis, with a sensitivity of 97.3%, specificity of 94.8%, and accuracy of 96.2% [10] . However, for a precise MRI examination, infants usually require procedural sedation or a general anesthesia.
The development of an early, non-invasive and accurate diagnosis system for BA is required for the better management of BA. The novel nomogram developed by Dong et al. [3] using GGT in combination with BA-related factor holds promise for future clinical application.
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